Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.28p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.38
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 6,262m
  • Volume: 44,634,882
  • Market Cap: £17.22m

Latest ShareCast News

Graft Polymer to buy Awakn in £4.98m deal

By Michele Maatouk

Date: Monday 16 Dec 2024

(Sharecast News) - Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, for £4.98m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.28p
Change Today 0.005p
% Change -1.79 %
52 Week High 0.38
52 Week Low 0.12
Volume 44,634,882
Shares Issued 6,262m
Market Cap £17.22m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
16:35 18,000 @ 0.28p
16:35 18,000 @ 0.28p
16:27 400 @ 0.30p
16:27 500 @ 0.28p
16:27 4,171 @ 0.28p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page